PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26495296-4	2015	In the present work, we report the fully compliant GMP-grade production of ATMP-CD133 which aims to address the treatment of chronic refractory ischemic heart failure.	guanosine 5'-monophosphorothioate	51-54	prominin 1	Homo sapiens	80-85	
19627397-0	2010	GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.	guanosine 5'-monophosphorothioate	0-3	prominin 1	Homo sapiens	10-15	
19627397-5	2010	These criteria and procedures were successfully applied to GMP production of CD133(+) cells from the BM for an ongoing clinical trial of autologous stem cells administration into patients with ischemic cardiomyopathy.	guanosine 5'-monophosphorothioate	59-62	prominin 1	Homo sapiens	77-82